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Abstract.  Inflammatory cells are capable of degrading 
extracellular matrix  macromolecules in vivo in the 
presence of proteinase inhibitors.  We and others have 
hypothesized that such proteolysis is permitted in large 
part by mechanisms operative in the immediate peri- 
cellular environment,  especially at zones of contact 
between inflammatory cells and  insoluble matrix com- 
ponents.  To further test this hypothesis in vitro, we 
have used a  model system in which viable polymor- 
phonuclear neutrophils  (PMN) are allowed to contact a 
surface coated with proteinase-sensitive substrate,  and 
in which PMN interaction  with the surface can be 
modulated.  We have evaluated proteolysis of the 
surface-bound protein in the presence and absence of 
proteinase inhibitors.  Our results were:  (a) In the pres- 
ence (but not in the absence) of proteinase inhibitors, 
proteolysis was confined to sharply marginated zones 
subjacent to the cells;  (b) opsonization of the surface 
enhanced spreading of the PMN,  (c) opsonization 
diminished the effectiveness of alpha-l-proteinase  in- 
hibitor (alpha-l-PI)  and alpha-2-macroglobulin  as in- 
hibitors of proteolysis of surface-bound protein;  (d) 
anti-oxidants  did not alter the effectiveness of alpha-1- 
PI in inhibiting proteolysis of opsonized substrate by 
PMN; and (e) PMN could restrict entry of alpha-l-PI 
into zones of contact with opsonized surfaces.  We con- 
clude that:  (a) In the presence of proteinase inhibitors, 
PMN can express sharply marginated and exclusively 
pericellular proteolytic activity; (b) locally high pro- 
teinase concentrations and/or exclusion of proteinase 
inhibitors  from pericellular microenvironments  may be 
important  mechansims for pericellular matrix  degrada- 
tion by PMN; and (c) these observations may have 
general  relevance to extracellular matrix  remodeling by 
a variety of inflammatory and other cell types. 
p 
ROTEINASES derived  from  inflammatory  cells  have 
been considered to play major roles in extracellular 
matrix  turnover both in health and disease.  Since the 
plasma and interstitial  space are replete with inhibitors  of a 
spectrum  of  proteinases  (48),  hypotheses  regarding  the 
mechanisms  for proteolysis of extracellular  matrix  must al- 
low for the occurrence of proteolysis in the presence of pro- 
teinase  inhibitors  (11). 
Considerable recent attention has focused upon polymor- 
phonuclear  neutrophils  (PMN) t,  and  especially upon the 
elastase  of PMN (human  leukocyte  elastase,  or HLE; EC 
3.4.21.11) in considerations  of matrix  turnover at inflamma- 
tory foci (1, 23, 45-47,  53).  HLE confers upon PMN the 
potential for powerful proinflammatory  and matrix degrada- 
tive capacity through its ability to degrade a spectrum of ma- 
trix components in addition  to elastin  (5, 6, 21, 22, 28, 33, 
34,  38, 42, 43,  54).  Evidence for HLE activity  in the ex- 
tracellular  space has been provided by the demonstration  of 
1. Abbreviations used in this paper:  Alpha-l-PI, alpha-l-proteinase inhibi- 
tor;  FN,  fibronectin; FN-IgG, fibronectin-coated surface opsonized with 
anti-fibronectin lgG; HLE,  human leukocyte (neutrophil) elastase; HSA, 
human serum albumin; PMN, polymorphonuclear neutrophil. 
a fibrinopeptide A-containing peptide (fibrinopeptide A-alpha 
1-21) in plasma (54). The sites of this activity are unknown; 
the mechanisms  permitting  such extracellular  HLE activity 
in the presence of proteinase inhibitors  are of considerable 
interest. 
It has been suggested that PMN might degrade extracellu- 
lar matrix  in the presence of inhibitors:  (a) by inactivating 
the HLE-inhibitory capacity of alpha-l-proteinase  inhibitor 
(alpha-l-PI)  by means  of the myeloperoxidase/H202/halide 
system  (18, 36,  37,  53)  and/or products of single-electron 
reduction  of oxygen liberated  during  the respiratory  burst 
(12, 14); (b) by oxidative inactivation of antileukoproteinase 
(13, 26, 27, 31, 39); and/or (c)by oxidant-independent  mecha- 
nisms at sites of cell-substrate  contact (7, 10, 11, 46, 50). The 
first two mechanisms could be operative at sites where alpha- 
1-PI and/or  anti-leukoproteinase  were  the  major  or  only 
effective inhibitors,  while the latter may be a more general 
mechanism. 
We have hypothesized that inflammatory cell-derived  pro- 
teolysis of extracellular  matrix in the presence of proteinase 
inhibitors  is limited to the immediate  pericellular  zone (10, 
11). To evaluate this hypothesis in vitro and to further explore 
local mechanisms  for proteolysis  in the presence of inhibi- 
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tory ceils are permitted to contact the susceptible substrate. 
Our results confirm that most of the proteolysis by PMN in 
the presence of inhibitors is confined to the pericellular area, 
indicate that close contact between the cells and the subja- 
cent  substrate  is  important in permitting  proteolysis,  and 
provide the basis for further insights into proteolytic activity 
in the presence of inhibitors. 
Materials and Methods 
Materials 
N-hydroxysuccinimidobiotin, avidin, dichlorotriazinylaminofluorescein  di- 
hydrochloride, BSA, catalase, superoxide dismutase, and dimethyl sulfox- 
ide were obtained from Sigma Chemical Co. (St. Louis, MO) Methoxysuc- 
cinyl  ala-ala-pro-val  chloromethyl ketone  was purchased from  Enzyme 
Systems Products, (Dublin, CA). 
Human Proteins 
Purified human plasma fibronectin (FN) was generously provided by Dr. 
J. A. McDonald, Washington University Medical Center (St. Louis, MO). 
Purified alpha-l-PI was obtained from Dr. J. A. Pierce, Washington Univer- 
sity Medical Center.  Purified human plasma alpha-2-macroglobulin (32) 
was provided by Dr. J. S. Huong, St. Louis University (St.  Louis, MO). 
Human serum albumin (HSA) was obtained from the American Red Cross 
(St. Louis, MO). HLE was purified from purulent sputum, as previously 
described  (35).  Biotinylation  and  fluoresceination  of  alpha-l-PI  was 
achieved by conventional methods (3, 20). 
Cells 
Human PMN were obtained from peripheral blood by ficoll-Hypaque cen- 
trifugation and dextran sedimentation (4).  Differential counting was per- 
formed on cytocentrifuge preparations (Cytospin 2, Shandon Southern In- 
struments, Sewickley,  PA), and revealed t>95 % PMN, with the remainder 
of the cells being eosinophils. These preparations did not contain mono- 
cytes, lymphocytes, or platelets. 
Proteinase Assay 
FN proteolysis by PMN was quantified in a solid phase assay as previously 
described (10). Briefly,  96-well microtiter plates (Nunc Immunoplate II) 
were coated with FN (5 tag/well).  The FN was labeled with [125I]NaI (100 
mCi/ml;  Amersham Corp.  Arlington Heights,  IL)  by the Enzymobead 
method (Bio-Rad, Richmond, CA). The [1251]FN, after mixing with unla- 
beled FN to yield a specific activity of ,~14,000 CPM/tag, was added to mi- 
crotiter wells which were then dried at room temperature and exhaustively 
washed to remove unbound FN. Proteolytic activity was quantified by mea- 
suring release of ~25I-labeled fibrinogen degradation products into the wells 
(Model  1272 Clinigamma, LKB-WaUac) after 3 h, 37~  5% CO2 in air. 
This solid phase assay system has been shown to be sensitive to nanogram 
quantities of proteinases, to be specific for proteinase activity,  and to ac- 
curately quantify FN proteolytic activity of viable PMN (10). PMN-derived 
proteolytic activity in this model system is nearly completely attributable 
to HLE, as demonstrated by >90% inhibition of PMN-derived proteolysis 
by the elastase-specific inhibitor methoxy-ala-ala-pro-val chloromethyl ke- 
tone (10). Additionally, in preliminary experiments, SDS-polyaerylamide 
gels followed by autoradiography revealed that 125I released during incu- 
bation with PMN consisted of FN peptides characteristic of those resulting 
from catalytic activity of HLE, but no intact FN. Assays were incubated in 
RPMI-1640  salts (The Tissue Culture Support Center, Washington Univer- 
sity Medical Center) unless otherwise specified, at 37~  in 5% CO2/air. 
Previous studies have documented that PMN introduced into this assay sys- 
tem rapidly settle (<5 min) onto the FN-coated surface and adhere (10). 
When proteinase inhibitors were included in the assays, they were added 
simultaneously with cells or proteinase. 
Opsonization of FN 
To modulate PMN interaction with the FN-coated surfaces, the microtiter 
wells were incubated with rabbit anti-FN IgG or (as a control) anti-FN Fab' 
fragments for 90 min at 37~  then the wells were washed exhaustively to 
remove unbound antibody. All anti-FN antibodies were generously pro- 
vided by Dr. J. A. McDonald (Washington University Medical Center). Pre- 
liminary experiments with a direct enzyme-linked immunosorbent assay 
technique (horseradish peroxidase-coupled goat anti-rabbit IgG; Cappel, 
Malvern, PA) established that 5  tag IgG or Fab' yielded maximal binding 
of immunoglobulins to the surface; this amount was used in the described 
experiments. Viable PMN (20,000/well)  or purified HLE (20 rig/well) were 
introduced into coated wells in the presence or absence of proteinase inhib- 
itors. 
Immunolocalization of  FN Proteolysis 
To evaluate the hypothesis that FN proteolysis in the presence of inhibitors 
occurred subjacent to the cells, FN was coated onto glass microscope slides 
(Lab-Tek chamber slides; Miles Laboratories, Naperville, IL). FN,  15 tag 
in 200 tal, was added to the chambers and dried at room temperature, then 
the slides were exhaustively washed to remove unbound FN. To modulate 
PMN attachment and spreading, the FN-coated surface could then be over- 
laid with rabbit anti-FN IgG or FaIY as described above (10 tag/chamber). 
Proteinase  inhibitors  (either alpha-l-PI or  alpha-2-macroglobulin)  were 
added simultaneously with the PMN where specified. 
After incubation with PMN (50,000  PMN/chamber, 45 min, 37~  5% 
CO2/air),  the cells were fixed and permeabilized with absolute ethanol. 
Residual surface-bound FN was then localized by indirect immunofluores- 
cence  using  murine  monoclonal  anti-FN  Fab'  fragments  followed by 
species-specific goat anti-mouse F(ab')2 fragments conjugated to fluores- 
cein (Cappel Laboratories, Malvern, PA).  After removal of the chambers 
from the slides, coverslips were applied over a mounting medium of 25% 
glycerol in PBS containing 250 tag/ml p-phenylenediamine to reduce pho- 
tobleaching. The slides were examined by phase contrast and epifluores- 
cence microscopy (Leitz Dialux 20,  Ernst Leitz Westlar GMBH). 
PMN Spreading 
PMN were introduced into Miles Lab-Tek chamber slides (Miles Laborato- 
ries) which were first coated with FN (15 tag/well).  Some of the FN-coated 
surfaces were overlaid with either: (a) rabbit polyclonal or murine monoclo- 
nal  anti-FN  IgG;  (b)  anti-FN  Fab' fragments;  (c)  routine  monoclonal 
anti-FN IgM; or (d) anti-FN IgM followed by fresh human serum (1:250 
dilution) as a source of complement. All of the chambers were exhaustively 
washed to remove nonadherent proteins. 
PMN were introduced into the chambers and observed by phase contrast 
optics (Nikon Diaphot-TMD) via a video camera (Series 67,  Dage-MTI, 
Michigan City, IN) interfaced with microcomputer-based image analysis 
software (SMI Microcomp) and a  digitizing pad (Hipad,  Houston Inst., 
Austin,  TX).  After incubation  for 20  rain,  PMN  were  fixed with 3% 
glutaraldehyde (30 min, 4~  then the area of spreading of the cells was 
quantified for ,~100 cells in each chamber. In additional experiments, PMN 
were fixed with glutaraldehyde after spreading and examined using Hoffman 
modulation contrast optics (Leitz). 
Exclusion of  Alpha-l-Pl  from Zones of  Contact 
between Neutrophils and Surfaces 
To evaluate  the possibility that PMN might be able to exclude proteinase 
inhibitors from diffusing freely into their zones of contact with surfaces, 
alpha-l-PI penetration beneath adherent PMN was examined. Miles Lab- 
Tek chamber slides were coated with a mixture of FN (8 tag) and avidin 
(50 tag). Where desired, this could be overlaid with rabbit anti-FN IgG 
or Fab' fragments as described above.  The chambers were exhaustively 
washed, then PMN were added and allowed to adhere and spread for 5 min. 
Biotinylated, fluoresceinated alpha-l-Pl was then added for an additional 10 
min. The slides were washed, fixed with absolute ethanol, then examined 
by phase contrast and epifluorescence microscopy. This experimental de- 
sign allowed binding of the biotinylated inhibitor to the avidin-coated sur- 
face wherever it had access, and allowed detection of the bound inhibitor 
by its fluorescence. To exclude the possibility that failure of binding of bio- 
tinylated inhibitor to the surface might be due to avidin proteolysis by the 
PMN, control cells were fixed and permeabilized with absolute ethanol be- 
fore addition of the biotinylated, fluoresceinated alpha-l-PI. This allowed 
penetration of the biotinylated inhibitor to zones subjacent to the fixed cells, 
where it could then bind to avidin present on the surface. 
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Figure 1. Inhibition of  proteolysis of surface-bound FN by alpha-l-Pl. (a) Inhibition of activity of  20 ng of  purified HLE by varying amounts 
of inhibitor. Note that inhibition is nearly complete when 62.5 ng of inhibitor (~1,4:1 molar ratio of inhibitor to enzyme) was added simul- 
taneously with enzyme, and that higher amounts of inhibitor completely inhibited enzymatic activity. Bars represent means,  +SD (n = 
4). (b) Inhibition of proteolytic activity of viable PMN. 20,000 PMN were added simultaneously with varying amounts of inhibitor. PMN 
were unstimulated except for effects  of contact with the surface. Note that marked excess of inhibitor yields incomplete inhibition of pmteo- 
lytic activity of the PMN on the FN (control, open  bars) surface. Inhibition of proteolysis of the FN-Fab' surface (hatched  bars) was similar 
to control. For all inhibitor concentrations, inhibition of proteolysis of the FN-IgG surface (solid  bars) was markedly reduced. Error bars 
=  SD; n  =  3. 
Results 
Proteolysis in the Absence of  Proteinase Inhibitors 
Proteolytic activity  of unstimulated  PMN  obtained  on  a 
given day and assayed using the same lot of FN-coated plates 
showed a mean coefficient of variance of 11% in five separate 
experiments. In these experiments, the FN proteolysis by 
20,000 unstimulated PMN (n  =  15) was 1,981 +  SEM 344 
CPM. For comparison, 20 ng of HLE released 1,867 +  99 
CPM 125I in parallel assays (n  =  3). 
In  the  absence  of proteinase  inhibitors,  proteolysis by 
PMN when the FN was opsonized with anti-FN IgG (FN- 
IgG)  was  not significantly changed;  the mean proteolysis 
was  103  +  SEM 7 % of paired unstimulated control values 
(n =  15). Similarly, proteolysis by PMN of FN coated with 
anti-FN Fab' fragments (FN-Fab') was 102 +  3 % of control 
(n =  15). For comparison, proteolysis of non-opsonized FN 
by PMN stimulated with phorbol myristate acetate (PMA, 
10 ng/ml) was 295 +  29 % of control (n =  15, P <  0.001 by 
t-test). Thus, in contrast to the response to PMA, contact of 
PMN with an opsonized surface did not enhance proteolytic 
activity in this model in the absence of proteinase inhibitors. 
Effect of  Alpha-l-PI Upon FN Proteolysis 
Proteolytic activity of 20 ng of leukocyte elastase was in- 
hibited 92% by 62.5 ng of alpha-l-PI (~1.4 molar excess of 
inhibitor added simultaneously with the enzyme), and essen- 
tially  no  proteolytic  activity  was  observed  with  higher 
amounts of inhibitor (Fig. 1 a). In marked contrast, alpha-1- 
PI was  less effective in inhibiting FN proteolysis by viable 
PMN.  Results  of one of five experiments performed are 
shown in Fig.  1 b; all gave similar results. As shown by the 
open  bars,  complete  inhibition  of  proteolysis  was  not 
achieved by amounts up to 12.5 p~g of inhibitor (62.5 p.g/ml). 
The FN-coated surface was also overlaid with anti-FN Fab' 
fragments or with anti-FN IgG in an attempt to modify the 
interaction of PMN with the surface. Fig.  1 b additionally 
shows inhibition, by amounts of alpha-l-PI up to 200 ~tg/as- 
say (1.0 mg/ml), of PMN-mediated proteolysis of the FN on 
these surfaces. Proteolytic inhibition of PMN on FN (con- 
trol) and FN-Fab' surfaces was  similar.  Inhibition of PMN 
proteolysis on FN-IgG,  however, was markedly less com- 
plete for all alpha-l-PI concentrations tested. Further studies 
(not shown) demonstrated that alpha-l-PI inhibition of PMN 
proteolytic activity toward FN was not significantly changed 
in comparison with control when the FN was overlaid with 
murine monoclonal anti-FN IgM or with anti-FN IgM plus 
dilute human  serum  (as  a  source of complement).  Since 
PMN on FN-IgG did not express more proteolytic activity 
in  the  absence of inhibitors,  these data  indicated that  Fc 
receptor-mediated interaction of PMN with the opsonized 
surface reduced the capability of alpha-l-PI to inhibit the 
PMN-derived elastase. 
Effect of  Anti-Oxidants Upon Inhibition of 
Neutrophil Proteolysis of Opsonized FN 
Preliminary  experiments  demonstrated  that  a  mixture  of 
anti-oxidants (catalase,  1,000 U/ml;  superoxide dismutase, 
50 ~g/ml; and DMSO,  1% vol/vol) maximally impaired the 
ability of PMA-stimulated  PMN  to oxidatively inactivate 
alpha-l-PI. This anti-oxidant mixture had no effect upon FN 
proteolysis by either viable PMN or purified HLE, and also 
had no effect upon inhibition by alpha-l-PI of the activity of 
purified HLE against FN (not shown). 
The effects of this anti-oxidant mixture upon inhibition of 
PMN proteolysis of FN can be seen in Fig. 2. Anti-oxidants 
did not enhance inhibition of PMN proteolysis of FN, FN- 
Fab', or FN-IgG. This finding indicates either that oxidative 
inactivation of the alpha-l-PI did not contribute to the incom- 
plete inhibition of PMN proteolysis on the FN-IgG surfaces, 
or that oxidative inactivation of the inhibitor was occurring 
at sites which were not accessible to the anti-oxidants (49). 
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Figure 2. Effect of anti-oxidants upon inhibition of PMN proteoly- 
sis by 3 gg of aipha-l-PI.  Inhibition of proteolytic activity was mea- 
sured  in the absence (open bars) or presence (hatched bars) of a 
mixture of anti-oxidants  (catalase,  1,000 U/ml; superoxide  dismu- 
tase, 50 gg/ml; and DMSO,  1% vol/vol). Error bars  =  SD; n =  3. 
Neutrophil Spreading 
We have previously shown that PMN introduced into our mi- 
crotiter well assay system settle to the bottom surface of the 
well,  adhere,  and spread  on the surface within 5  min (10). 
PMN  spreading,  as  assessed by Hoffman modulation con- 
trast  microscopy,  was  strikingly  enhanced  when  the  cells 
were in contact with FN-IgG as compared with either FN or 
FN-Fab' (Fig.  3).  The cells on FN or FN-Fab' displayed a 
rounded morphology, and were loosely adherent to the sur- 
face. This is in agreement with studies by reflection contrast 
microscopy (29) which showed very small contact patches of 
unstimulated PMN with substratum. In marked contrast, the 
cells on FN-IgG were highly spread  and flattened. 
Quantification of spreading of PMN by phase contrast mi- 
croscopy is shown in Fig. 4.  The areas of spreading of the 
PMN were 122  _  43 (mean  ___ SD; n  =  97) and 263  +  86 
(n  =  106)  for  FN-Fab' and  FN-IgG,  respectively.  These 
differences were highly significant (P ,~ 0.001  by t-test), and 
clearly demonstrate that adherence to the FN-IgG surface, 
in contrast to FN-Fab', markedly enhanced the observed cell 
spreading. The mean area of spreading of PMN on FN-IgM, 
and  Fn-IgM  +  complement,  was  not greater  than  that of 
cells on Fn-Fab' (not shown).  Enhanced spreading  was ob- 
served only when the FN was overlaid with anti-FN antibod- 
ies which contained Fc fragments.  These data indicate that 
contact  of PMN  with  the  FN-IgG  surface  markedly  in- 
creased cell  spreading,  mediated by Fc receptor binding. 
Immunolocalization of Proteolysis 
Preliminary  experiments  (not shown) demonstrated that in 
the absence of inhibitors,  PMA-stimulated  PMN gradually 
degraded FN in expanding zones around the cells over time 
until no immunoreactive FN remained after 1-2 h. The effect 
of proteinase inhibitors (not shown) was to protect substrate 
in the areas remote from the cell surface; however, proteoly- 
sis subjacent to the cells was still observed. Fig. 5 shows the 
contrast between proteolysis of FN-Fab' and of  FN-IgG in the 
presence of alpha-l-PI (250 Ixg/ml in this experiment, but the 
concentration of inhibitor was not critical to the results ob- 
Figure 3. Modulation contrast microscopy of PMN allowed to ad- 
here and spread on various surfaces. See text for details. (A) Surface 
coated with FN only. (B) Surface coated with FN +  anti-FN Fab' 
fragments.  (C) FN-IgG surface.  Note that  PMN on FN-IgG are 
more tightly  adherent  and spread  than cells on either the control 
or FN-Fab' surface.  Bar  =  10 Ixm. 
rained).  A  reasonably uniform coating of the  surface with 
immunoreactive FN was observed in the absence of added 
cells (Fig. 5 a).  Minimal to absent nonspecific fluorescence 
was observed  when nonimmune Fab' fragments  were  sub- 
stituted  for anti-FN  Fab' fragments  in the immunostaining 
(not  shown).  When  unstimulated  PMN  were  added,  rare 
localized  areas  of FN  proteolysis  on  the  FN-Fab' surface 
(Fig.  5  b)  were associated  with  rounded adherent cells  by 
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Figure 4. Spreading of PMN allowed to adhere to FN-FalY and FN- 
IgG. PMN were allowed to adhere and spread for 20 min at 37~ 
in the presence of alpha-l-PI (50 Ixg/ml), then fixed with glutaralde- 
hyde; the area of spreading was quantified by a microcomputer- 
based image analysis system. PMN in contact with FN-IgG spread 
avidly on the surface (P ,~ 0.001 in comparison with FN-Fab' by 
t-test). 
phase contrast microscopy. In marked contrast (Fig. 5, c and 
e),  striking and sharply marginated FN proteolysis of the 
FN-IgG surface was observed. During the 45-min incuba- 
tion the cells traveled a distance of 4-10 cell diameters, in 
linear or curvilinear paths, on FN-IgG. Very localized and 
usually sharply delimited zones of total clearing of immuno- 
reactive FN from the surface were found in each cell's path. 
Zones of partial proteolysis were also observed, but were 
decidedly less common. The zones of  proteolysis were rounded 
or irregularly shaped and varied in size down to <1.0  Ixm. 
The largest zones of complete clearing of substrate were of- 
ten at the initial site of adherence to the surface. 
When  alpha-2-macrogiobulin  was  present  at  the  time 
PMN were added (Fig. 6), proteolysis was again prevented 
in  the  intercellular zones,  but permitted subjacent to the 
cells.  The  zones  of proteolysis  observed  with  alpha-2- 
macroglobulin as the inhibitor were broader and comprised 
nearly the entire breadth of the cell. This observation is con- 
sistent with our previous studies in a similar model system 
(10), which showed that inhibition by alpha-2-macroglobulin 
of PMN-derived proteolysis was less complete than inhibi- 
tion by alpha-l-PI. 
Exclusion of  Alpha-l-Pl  from Zones Subjacent 
to Attached Neutrophils 
PMN were allowed to attach and spread on FN-Fab' or FN- 
IgG surfaces to which avidin was also bound. Subsequent ad- 
dition of biotinylated, fluoresceinated alpha-l-PI allowed the 
inhibitor probe to bind to the surface wherever it was permit- 
ted to have access.  Subsequent examination by epifluores- 
cence microscopy (Fig.  7)  allowed identification of zones 
into which diffusion of the inhibitor probe was restricted. 
In the absence of cells (Fig. 7 a), a uniform lawn of bound 
fluorescent probe was observable. When avidin was absent 
from the surface (Fig. 7 b), minimal nonspecific binding of 
the fluorescent probe was detected. When PMN were adher- 
ent to FN-Fab', an uninterrupted lawn of fluorescence was 
again observed, despite the presence of attached cells (Fig. 
7, c and d). In contrast, when PMN were allowed to attach 
to FN-IgG, zones of restricted access of the probe were iden- 
tified which corresponded to the area immediately subjacent 
to each cell, as identified by phase-contrast microscopy (Fig. 
7, e andf). 
To exclude the possibility that the reduced fluorescence 
subjacent to the cells resulted from proteolysis of avidin in 
those zones, control preparations were fixed and permeabi- 
lized with ethanol before addition of the probe (Fig. 7, g and 
h).  An uninterrupted lawn of bound fluorescent probe was 
seen,  indicating  that avidin  was  still  present beneath the 
cells. The reduced or absent subcellular binding of the bio- 
tinylated probe seen in Fig.  7 e was thus due to restricted 
access of inhibitor to the area beneath the cells, rather than 
to avidin proteolysis. 
Discussion 
The experiments described extend our prior observations of 
proteolytic activity of PMN while in contact with a suscepti- 
ble substrate (10). In earlier work, we found that alpha-l-PI 
and alpha-2-macroglobulin incompletely inhibited proteoly- 
sis of surface-bound FN in a similar model when the cells 
were allowed to contact the substrate. We hypothesized that 
the  inhibitors  were  partially  excluded from the  interface 
between PMN and the substrate,  allowing relatively unre- 
strained proteolysis to occur in that microenvironment (10). 
In the present work, we have confirmed that while proteinase 
inhibitors  (alpha-l-PI  and  alpha-2-macroglobulin) prevent 
PMN-derived proteolysis in zones distant from the cell sur- 
face, they are ineffective in protecting substrate immediately 
subjacent to the cells. 
We chose to use a  stimulus to PMN activation (contact 
with an opsonized surface) which is relevant to acute inflam- 
mation in a variety of disease states.  Our work demonstrated 
that substrate opsonization, mediated by PMN Fc receptor 
binding, markedly enhanced spreading of the cells on the sur- 
face and reduced penetration of alpha-l-PI (and presumably 
also alpha-2-macroglobulin, which has approximately a  13- 
fold larger molecular radius) into zones of contact between 
the cells and the substrate. It was of interest that, in the ab- 
sence of inhibitors, proteolytic activity of PMN spread on an 
opsonized surface was not different from that of cells on con- 
trol surfaces. In contrast, when proteinase inhibitors (either 
alpha-l-PI  or  alpha-2-macroglobulin)  were  present,  sub- 
strate opsonization markedly diminished the effectiveness of 
the inhibitors. This indicates that, in this model, the predom- 
inant effect of opsonization of the surface was to promote ex- 
tensive and close interaction of the cells with the surface, 
Campbell  and Campbell Per&'etlular Proteolysis by Neutrophits  671 Figure  5. Immunotocalization of PMN proteolysis in the presence of alpha-l-Pl (250 ~tg/ml). PMN (50,000/chamber) were introduced into 
chambers of Miles glass chamber slides (Miles Laboratories) coated with human plasma FN. The slides, with adherent PMN, were fixed 
with ethanol and stained for FN by indirect immunofluorescence following a 45-min incubation. See text for details. (A) Lawn of fibronectin 
observed when PMN were omitted. (B) Rare zone of absent FN, associated with rounded cell by phase contrast (not shown), observed 
when unstimulated PMN were present during the incubation on FN-Fab'.  (C and  D) Epifluorescence and phase contrast,  respectively, 
of otherwise unstimulated PMN on FN-IgG, showing strikingly localized zones of FN proteolysis corresponding only to zones of PMN 
migratory paths. Note that FN is protected by the inhibitor in the zones between cells, and that proteolytic zones are very sharply marginated. 
Quite elongated PMN profiles were often revealed by phase contrast microscopy. (E and F) Epifluorescence and phase contrast microscopy, 
respectively, of PMN on FN-IgG, showing details of proteolysis by two PMN. Again note strikingly localized and sharply marginated zones 
of proteolysis, ranging in size down to x<l Inn. Bars,  10 ~tm. 
such that local proteolysis could not be prevented by inhibi- 
tor. The poorer inhibition by alpha-2-macroglobulin in com- 
parison with alpha-l-PI, and the broader zones of PMN pro- 
teolysis  in  the  presence  of  alpha-2-macroglobulin  in  the 
present work,  would be consistent  with poorer penetration 
of the larger inhibitor  into areas beneath  the cells. 
We (10, 11) and others  (40,  44,  46,  50)  have earlier  sug- 
gested  the possibility  that proteolysis by PMN,  especially 
in the presence of proteinase  inhibitors,  takes place in the 
immediate  pericellular  space.  The  studies  reported  here 
confirm that hypothesis,  and indicate that proteinase inhibi- 
tors  are  effective  only  at  sites  remote  from  appropriately 
stimulated  cells. 
Oxidative and Nonoxidative Mechanisms of 
Proteolysis in the Presence of  lnhibitors 
As indicated by the present work, partitioning of proteinase 
inhibitors may provide a partial explanation for extracellular 
proteolysis in the presence of inhibitors.  In agreement with 
The Journal of Cell Biology. Volume 106, 1988  672 Figure 6. Immunolocalization of FN proteolysis in the presence of alpha-2-macroglobulin (50 Ixg/ml). Methods were as described for Fig. 
5. (a) Epifluorescence; (b) phase contrast. Note that alpha-2-macroglobulin prevented  proteolysis in the zones between cells, but that sharply 
marginated zones of absent FN are seen and correspond to the location of PMN. Bar, 10 lam. 
our data, monocyte-derived macrophages adherent to an op- 
sonized surface have been shown to exclude molecules as 
small  as  Fab  fragments  (Mr  =  50,000)  from penetrating 
into zones of contact between the cells and the surface (55). 
These cells have been thought to have the capacity to create 
a "closed compartment" in which the efficacy of secretory 
products is maximized, at sites of contact with the surface 
(24). Chapman and Stone (15) found that the elastolytic ac- 
tivity of PMN, in contrast to that of macrophages, was read- 
ily  inhibited  by  proteinase  inhibitors.  However,  in  those 
studies the PMN were unstimulated and presumably poorly 
adherent to the elastin particles used in the assay. 
Weiss (50) has classified PMN proteolysis in the presence 
of proteinase inhibitors as being permitted by either oxida- 
tive or nonoxidative mechanisms. In addition to partitioning 
of proteinase inhibitors, other nonoxidative mechanisms may 
have contributed to the proteolytic activity in our studies. 
Based upon reasonable assumptions, HLE can be estimated 
to be present in millimolar concentrations within azurophil 
granules of PMN (7, 8). Thus, at sites of azurophil granule 
release from the cells, very high concentrations of enzyme 
will be present, at least transiently, in the pericellular space. 
The rate of diffusion of enzyme away from local sites may 
vary depending upon the closeness of contact of the cell with 
target macromolecules; however, even brief exposure of ex- 
tracellular proteins to such high concentrations of HLE may 
result in significant proteolysis. In support of the possibility 
of high local enzyme concentrations, Henson (25) has re- 
ported that azurophil granule extrusion from PMN occurred 
predominantly at sites where PMN membrane was adherent 
to immune complexes, and occurred minimally along the 
free,  non-adherent membrane.  The possibility  thus  exists 
that locally very high HLE concentrations might occur at 
sites of contact of PMN membrane with immune complexes. 
Finally, it is possible that a portion of the HLE might remain 
on the PMN surface membrane when azurophil granules are 
released, as has been reported for alkaline phosphatase (25). 
In  endotoxin-stimulated  murine  macrophages  studied  by 
Chapman  et  al.,  membrane-bound  plasminogen  activator 
was resistant (while soluble plasminogen activator was sensi- 
tive) to inhibition by fluid-phase inhibitors (16). Membrane 
binding of HLE might occur due to the cationic and rela- 
tively insoluble nature of the enzyme, or by means of bind- 
ing to PMN surface receptors for HLE which have been de- 
scribed (19). 
Oxidative mechanisms which might permit proteolysis by 
PMN in the presence of either alpha-l-PI (12, 14,  18, 40, 53) 
or anti-leukoproteinase (13, 31) have received considerable 
attention.  Oxidants  released  by  PMN  during  respiratory 
burst  activity  have  been  shown  to  functionally  inactivate 
these inhibitors,  resulting in loss of their ability to inhibit 
released HLE. The predominant oxidizing species released 
by PMN appear to be the myeloperoxidase/H202/halide sys- 
tem (18, 36, 37), or hypochlorous acid/chloroamine products 
of myeloperoxidase activity (51, 52). In vivo, the extent and 
importance of oxidative inactivation of proteinase inhibitors 
may depend upon: (a) the intensity of PMN respiratory burst 
activity, which varies  with different stimuli,  (b)  the  local 
presence of anti-oxidants or competitive antagonists of in- 
hibitor inactivation (2, 9, 50); and (c) the local availability 
of alternative proteinase inhibitors such as alpha-2-macro- 
globulin. 
Anti-oxidants have improved the effectiveness of inhibi- 
tion by alpha-l-PI in some previous in vitro models (40, 50, 
53), but not in the present and some other previous studies 
(10, 44, 46).  These variable results may relate to failure of 
anti-oxidants to penetrate to sites of some oxidant activity in 
the pericellular microenvironment (49), or to technical de- 
tails of the in vitro assay systems. However, the proteolytic 
activity of PMN  from chronic g~ranulomatous  disease  pa- 
tients (50) and the local  ineffectiveness of alpha-2-macro- 
globulin in the present and previous (10) work demonstrate 
that oxidative inhibitor inactivation is not necessary for local 
proteolytic activity by PMN when in contact with an insolu- 
ble substrate.  Based upon the available evidence, it seems 
most reasonable to conclude that both oxidative and nonox- 
idative  mechanisms  may  permit  local  proteolytic activity 
when PMN are in close contact with insoluble substrates, but 
that  oxidative inhibitor inactivation may be necessary  for 
proteolytic activity more remote from the cell surface. 
Campbell and Campbell Pericellular Proteolysis by Neutrophils  673 Figure 7. Exclusion of alpha-l-PI from penetrating into zones subjacent to PMN. See text for details of methods.  (A) Lawn of biotinylated, 
fluoresceinated alpha-l-PI bound to surface coated with FN  +  avidin in the absence of PMN.  (B) Minimal to absent fluorescence when 
avidin was not present on the surface. (C and D) Epifluorescence and phase contrast, respectively, of PMN adherent to avidin +  FN-Fab'; 
note relatively uninterrupted fluorescence, with considerable nuclear autofluorescence. (E and F) Epifluorescence and phase contrast,  re- 
spectively, of PMN adherent to avidin +  FN-IgG. Zones of reduced fluorescence correspond exactly to margins of spread PMN, indicating 
areas of reduced binding of fluoresceinated biotin-alpha-l-PI. (G and H), epifluorescence and phase contrast, respectively, of PMN adherent 
to avidin +  FN-IgG, but fixed and permeabilized before addition of the biotinylated, fluoresceinated inhibitor. Uninterrupted fluorescence 
indicates that zones of reduced fluorescence in E  could not be attributed to avidin proteolysis by PMN, but rather were due to restricted 
access of the probe to zones subjacent to the cells.  Bar,  10  gm. 
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of PMN 
One of the most intriguing observations in the current experi- 
ments  was  the patchy and  sharply demarcated  proteolysis 
which occurred as PMN  traversed  the surface-bound sub- 
strate. These zones varied in size down to 1-2 ~tm, and larger 
zones  may  have  represented  confluence  of  a  number  of 
smaller  zones  of proteolysis.  Zones  of partial  or  poorly 
demarcated  proteolysis  were  uncommonly  observed  (Fig. 
5).  The mechanisms giving rise to this pattern are unclear, 
but the zones of proteolysis may: (a) occur at sites in close 
proximity  to  release  of an azurophil granule or granules; 
and/or (b) occur at sites of close contact between the migrat- 
ing PMN and the surface. With regard to the former possibil- 
ity, it is noteworthy that the size of the zones of proteolysis 
would be  in agreement  with the size of PMN  azurophilic 
granules ('~0.3-0.5  Ixm). The latter possibility is of interest 
because the closeness of contact between PMN and an op- 
sonized surface is quite varied over the area of spreading (29, 
30). Similar studies of fibroblasts by reflection contrast mi- 
croscopy have revealed that the estimated distance between 
the fibroblast cell membrane and a glass substratum varies 
from <50 to >600 angstroms. Chen et al. have identified very 
localized zones of FN proteolysis subjacent to transformed 
fibroblasts; these occur at sites of expression of pp60  ~rc anti- 
gen and at sites of rosette contacts with the surface (17).  In 
this  study,  we  were  not able  to assess  the possibility  that 
localized proteolysis occurred at sites of specialized contacts 
between PMN and the subjacent surface. 
Another interesting  observation  was  the controlled and 
continual release of proteolytic enzyme by PMN during the 
45-min migration on the opsonized surface. Although time- 
lapse photography was  not possible with our experimental 
design, it was apparent that proteolytic activity was continu- 
ally expressed by the PMN during migration, since localized 
areas of proteolysis were observed at all points along their 
paths. 
Although we  studied proteolysis  of FN,  we have previ- 
ously shown (10) that most or all of the FN degradation in 
this model system is attributable to HLE in models utilizing 
other substrates  (44,  46,  53)  HLE has also been found to 
provide nearly all of PMN-derived proteolytic activity. Our 
results thus may be relevant to the turnover of a number of 
extracellular  matrix  components,  since  HLE  has  a  broad 
substrate specificity which includes not only FN and elastin, 
but also types III and IV collagen (33, 34, 41, 42) and pro- 
teoglycans (28). 
The extensive pericellular proteolysis in our experiments 
which occurred in the presence of proteinase inhibitors may 
be highly relevant to in vivo proteolysis and suggest: (a) that 
the role of proteinase inhibitor(s) may be to spacially confine 
proteolytic activity; and (b) that examination of"proteinase- 
inhibitor balance" at a tissue or organ level may incorrectly 
suggest that proteinase inhibitors will be effective in prevent- 
ing extracellular proteolysis. Indeed,  recent work by Weitz 
et al.  (54) has indicated that HLE activity exists in the ex- 
tracellular space and that the products of such activity can 
be detected.  Hopefully, additional studies using intact cells 
in vitro, in model systems such as the one used in the present 
work,  will  lead to further insights into mechanisms of ex- 
tracellular matrix turnover in health and disease. 
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